Advertisement
Screener

HAGERTY, INC. (HGTY) Spending and interest coverage

HAGERTY, INC. (HGTY) Spending and interest coverage

  • R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
  • Stock-based compensation / revenue · 12 months: Value 3.95%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months(m)Research and development expense / revenue. Period ending 2026-06-30.

Calculation unavailable: missing inputs remain (m).

Stock-based compensation / revenue · 12 months3.95%Share-based compensation / revenue. Period ending 2026-06-30.

$19.08M ÷ $482.73M × 100 ≈ 3.95%

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending(m)
Revenue482.73M USDRevenue from Contract with Customer, Excluding Assessed Tax
Stock-based compensation19.08M USDShare-based Payment Arrangement, Noncash Expense
Operating income(m)Operating Income (Loss)
Interest expense · reported / estimated(m) · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2026-06-30(m)$482.73M$19.08M(m)(m)(m)3.95%(m)(m)
2026-03-31(m)$590.34M$19.13M(m)(m)(m)3.24%(m)(m)
2025-12-31(m)$677.63M$18.91M(m)(m)(m)2.79%(m)(m)
2025-09-30(m)$648.19M$18.97M$113.78M(m)(m)2.93%(m)(m)
2025-06-30(m)$613.66M$17.97M$89.55M(m)(m)2.93%(m)(m)
2025-03-31(m)$578.64M$17.21M$79.92M(m)(m)2.97%(m)(m)
2024-12-31(m)$548.76M$17.36M$66.42M(m)(m)3.16%(m)(m)
2024-09-30(m)$531.07M$17.88M$53.91M(m)(m)3.37%(m)(m)
2024-06-30(m)$509.17M$18.72M$59.94M(m)(m)3.68%(m)(m)
2024-03-31(m)$487.31M$18.45M$39.12M(m)(m)3.79%(m)(m)
2023-12-31(m)$468.35M$18.02M$10.41M(m)(m)3.85%(m)(m)
2023-09-30(m)$455.33M$17.12M$-18.84M(m)(m)3.76%(m)(m)
2023-06-30(m)$428.81M$16.04M$-56.19M(m)(m)3.74%(m)(m)
2023-03-31(m)$406.97M$16.24M$-71.05M(m)(m)3.99%(m)(m)
2022-12-31(m)$384.53M$12.13M$-67.57M(m)(m)3.15%(m)(m)
2022-09-30(m)$370.80M(m)$-52.85M(m)(m)(m)(m)(m)
2022-06-30(m)$350.91M(m)$-29.86M(m)(m)(m)(m)(m)
2022-03-31(m)$335.97M(m)$-17.98M(m)(m)(m)(m)(m)
2021-12-31(m)$323.25M(m)$-10.07M(m)(m)(m)(m)(m)
2021-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-03-31(m)$301.39M(m)$14.92M(m)(m)(m)(m)(m)
2020-12-31(m)$279.05M(m)$15.85M(m)(m)(m)(m)(m)
2020-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.